Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
3.600
+0.120 (3.45%)
At close: Feb 6, 2026, 4:00 PM EST
3.590
-0.010 (-0.28%)
After-hours: Feb 6, 2026, 7:31 PM EST
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $55.71 million as of February 6, 2026. Its market cap has increased by 39.62% in one year.
Market Cap
55.71M
Enterprise Value
38.84M
1-Year Change
39.62%
Ranking
Category
Stock Price
$3.60
Market Cap Chart
Since January 9, 2015, Grace Therapeutics's market cap has decreased from $6.81B to $55.71M, a decrease of -99.18%. That is a compound annual growth rate of -35.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 50.90M | 4.09% |
| Dec 31, 2025 | 48.90M | 29.02% |
| Dec 31, 2024 | 37.90M | 39.34% |
| Dec 29, 2023 | 27.20M | 21.43% |
| Dec 30, 2022 | 22.40M | -59.86% |
| Dec 31, 2021 | 55.80M | 77.14% |
| Dec 31, 2020 | 31.50M | -84.91% |
| Dec 31, 2019 | 208.70M | 584.26% |
| Dec 31, 2018 | 30.50M | 119.42% |
| Dec 29, 2017 | 13.90M | 3.73% |
| Dec 30, 2016 | 13.40M | -99.80% |
| Jan 9, 2015 | 6.81B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TScan Therapeutics | 58.45M |
| Metagenomi Therapeutics | 57.82M |
| NRx Pharmaceuticals | 56.55M |
| ImmuCell | 56.45M |
| PMV Pharmaceuticals | 55.34M |
| Tevogen Bio Holdings | 55.34M |
| Cingulate | 55.32M |
| Nutriband | 52.88M |